InvestorsHub Logo
Followers 21
Posts 4511
Boards Moderated 0
Alias Born 12/18/2009

Re: A deleted message

Tuesday, 08/24/2010 11:32:31 PM

Tuesday, August 24, 2010 11:32:31 PM

Post# of 129051
The only caveat (I can think of) is if the EU / Germany does not have the parental (FDA type) regulations that we employ (here) in the US.
That may afford cbis the ability to bring CBIS Made in the USA
or some other shenanigans to market in Germany. But my elementary mind would think that CBIS would have to operate under some sort of /Medical/ guidelines / licensing / permitting; all or any of witch will cost money (of witch cbis does not have).

I have a felling the only thing CBIS will be selling in Germany is paper. not zig zag type.
I see this as a ploy to list on a foreign exchange - for u know who; shorty.

I am personally disappointed in Mike Friedman, Mr. Cowan, Dr. Bob and the entire CBIS organization
I Know for a fact they are eating and sleeping well tonight - they shouldn't be - as they are failing.

anyone that posts otherwise is not being truthful either to themselves and/or to the group
I challenge you to definitively depict the Successes CBIS has accomplished; and renegotiating with rockbrook isn't an accomplishment it is a failed attempt with a compromise that will result in almost nothing once expenses are factored

Look back at press releases not from WAY WAY back, start in July.
but, Everything this company has released for the past year has fallen apart. The wishful revenue streams have eroded or vaporized entirely and we are left with press releases of intentional plans.

It is obvious and apparent to me that team CBIS has broken rule 1.
Don't get high on your own supply.

Im holding A BIG BAG and hoping for the best, but am doubtful. CBIS does not have the product supply lines in place to capture a market interest let alone a market presence should the Nov vote pass. imo


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.